The VergeHuman embryos reportedly edited for first time in the US using CRISPRThe VergeFor the first time, scientists in the US have successfully edited the DNA of viable human embryos using the powerful gene-editing tool CRISPR, according to a report … Continue reading
WhaTech |
Stem cell treatment kills cancer cells that have spread in mice
Cancer Research UK A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study. The researchers behind the work hope that, if it is shown to work in humans, the treatment could also help to prevent … Stem cell-based method selectively targets cancerous tissue while preventing toxic side effectsNews-Medical.net Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell …Genetic Engineering & Biotechnology News Mesenchymal stem cells market grows with increasing clinical application for the treatment of chronic disease …WhaTech MilTech all 6 news articles » |
|
Seattle Children’s Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia …
Newswise (press release) Newswise — SEATTLE – July 27, 2017 – After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete … |
|
Seattle Children’s Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia …
Newswise (press release) Newswise — SEATTLE – July 27, 2017 – After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete … |
|
Seattle Children’s opens CD22 CAR T-cell immunotherapy trial for …
Medical Xpress After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute … |